73 related articles for article (PubMed ID: 23890078)
1. Impact of the Scottish Bowel Cancer Screening Programme on patient and tumour characteristics at a single centre.
Mackay C; Ramsay G; Rafferty A; Loudon M
J Eval Clin Pract; 2014 Feb; 20(1):7-11. PubMed ID: 23890078
[TBL] [Abstract][Full Text] [Related]
2. Does the location of colorectal carcinoma differ between screened and unscreened populations?
Mackay CD; Ramsay G; Rafferty A; Loudon MA
Colorectal Dis; 2012 Oct; 14(10):e689-91. PubMed ID: 22726268
[TBL] [Abstract][Full Text] [Related]
3. Impact of the bowel-screening programme on the diagnosis of colorectal cancer in Ayrshire and Arran.
Roxburgh CS; McTaggart F; Balsitis M; Diament RH
Colorectal Dis; 2013 Jan; 15(1):34-41. PubMed ID: 22632378
[TBL] [Abstract][Full Text] [Related]
4. Interval cancers in a FOBT-based colorectal cancer population screening programme: implications for stage, gender and tumour site.
Steele RJ; McClements P; Watling C; Libby G; Weller D; Brewster DH; Black R; Carey FA; Fraser CG
Gut; 2012 Apr; 61(4):576-81. PubMed ID: 21930729
[TBL] [Abstract][Full Text] [Related]
5. A comparison of tumour and host prognostic factors in screen-detected vs nonscreen-detected colorectal cancer: a contemporaneous study.
Mansouri D; McMillan DC; McIlveen E; Crighton EM; Morrison DS; Horgan PG
Colorectal Dis; 2016 Oct; 18(10):967-975. PubMed ID: 26859503
[TBL] [Abstract][Full Text] [Related]
6. Patterns of uptake in a biennial faecal occult blood test screening programme for colorectal cancer.
Steele RJ; McClements PL; Libby G; Carey FA; Fraser CG
Colorectal Dis; 2014 Jan; 16(1):28-32. PubMed ID: 24034143
[TBL] [Abstract][Full Text] [Related]
7. Urgency of referral and its impact on outcome in patients with colorectal cancer.
Ramsay G; MacKay C; Nanthakumaran S; Craig WL; McAdam TK; Loudon MA
Colorectal Dis; 2012 Jul; 14(7):e375-7. PubMed ID: 22284530
[TBL] [Abstract][Full Text] [Related]
8. Temporal trends in mode, site and stage of presentation with the introduction of colorectal cancer screening: a decade of experience from the West of Scotland.
Mansouri D; McMillan DC; Crearie C; Morrison DS; Crighton EM; Horgan PG
Br J Cancer; 2015 Jul; 113(3):556-61. PubMed ID: 26158422
[TBL] [Abstract][Full Text] [Related]
9. The impact of colorectal cancer screening in a veteran hospital population.
Trombold J; Farmer RW; McCafferty M
Am Surg; 2013 Mar; 79(3):296-300. PubMed ID: 23461957
[TBL] [Abstract][Full Text] [Related]
10. Excellent performance of Hemoccult Sensa in organised colorectal cancer screening.
Kershenbaum A; Flugelman A; Lejbkowicz F; Arad H; Rennert G
Eur J Cancer; 2013 Mar; 49(4):923-30. PubMed ID: 23099005
[TBL] [Abstract][Full Text] [Related]
11. Survival impact of the Australian National Bowel Cancer Screening Programme.
Ananda S; Wong H; Faragher I; Jones IT; Steele M; Kosmider S; Desai J; Tie J; Field K; Wong R; Tran B; Bae S; Gibbs P
Intern Med J; 2016 Feb; 46(2):166-71. PubMed ID: 26418334
[TBL] [Abstract][Full Text] [Related]
12. Early detection of colorectal cancer with faecal occult blood test screening.
Paimela H; Malila N; Palva T; Hakulinen T; Vertio H; Järvinen H
Br J Surg; 2010 Oct; 97(10):1567-71. PubMed ID: 20603855
[TBL] [Abstract][Full Text] [Related]
13. Colorectal cancers detected through screening are associated with lower stages and improved survival.
Lindebjerg J; Osler M; Bisgaard C
Dan Med J; 2014 Jan; 61(1):A4758. PubMed ID: 24393588
[TBL] [Abstract][Full Text] [Related]
14. Screening vs. non-screening detected colorectal cancer: Differences in pre-therapeutic work up and treatment.
Saraste D; Martling A; Nilsson PJ; Blom J; Törnberg S; Janson M
J Med Screen; 2017 Jun; 24(2):69-74. PubMed ID: 27470598
[TBL] [Abstract][Full Text] [Related]
15. [Early detection of bowel cancer in occupational surveillance examinations: switching from a guaiak-based to an immunochemical fecal occult blood test].
Webendörfer S; Riemann JF
Dtsch Med Wochenschr; 2014 Jan; 139(3):79-83. PubMed ID: 24089288
[TBL] [Abstract][Full Text] [Related]
16. The NHS Bowel cancer screening programme achieves the anticipated survival improvement, but participation must be improved.
Borowski DW; Cawkwell S; Zaidi SMA; Toward M; Maguire N; Garg DK; Gill TS
Int J Health Care Qual Assur; 2018 Mar; 31(2):106-115. PubMed ID: 29504872
[TBL] [Abstract][Full Text] [Related]
17. Symptoms do not predict colorectal cancer in an FOB screened population.
Saldanha JD; Moug SJ; Linton K; Diament RH
Scott Med J; 2013 May; 58(2):95-8. PubMed ID: 23728754
[TBL] [Abstract][Full Text] [Related]
18. Round one of the Adelaide and Meath Hospital/Trinity College Colorectal Cancer Screening Programme: programme report and analysis based on established international key performance indices.
McNamara D; Qasim A; Lee N; Condon C; O'Morain C
Ir J Med Sci; 2011 Jun; 180(2):549-52. PubMed ID: 21264524
[TBL] [Abstract][Full Text] [Related]
19. High yield of colorectal neoplasia detected by colonoscopy following a positive faecal occult blood test in the NHS Bowel Cancer Screening Programme.
Lee TJ; Clifford GM; Rajasekhar P; Rutter MD; Kometa S; Ritchie MC; Waddup G; Nylander D; McNally RJ; Rees CJ
J Med Screen; 2011; 18(2):82-6. PubMed ID: 21852700
[TBL] [Abstract][Full Text] [Related]
20. Differences in screening history, tumour characteristics and survival between women with screen-detected versus not screen-detected cervical cancer in the east of The Netherlands, 1992-2001.
van der Aa MA; Schutter EM; Looijen-Salamon M; Martens JE; Siesling S
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):204-9. PubMed ID: 18093720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
